Skip to main content
Clinical Trials/NCT02236130
NCT02236130TerminatedNot Applicable

Peripheral Nerve Blocks in Pediatric Orthopedic Patients: Are There Any Post Recovery Benefits?

University of Mississippi Medical Center1 site in 1 country49 target enrollmentStarted: June 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
49
Locations
1
Primary Endpoint
Total Hydrocodone Dose (mg/kg)

Study Overview

Brief Summary

Context:

Single shot peripheral nerve blocks have limited duration of action depending on the local anesthetic agent used in the block. But it rarely lasts longer than 12 hrs. Patients need oral analgesics at home once the block wears off to control the pain.

Objectives:

Primary Objective

To determine if peripheral nerve blocks have any advantage in terms of decreasing oral analgesic requirements in the post operative period even after the effects of the block have worn off

Secondary Objective

To determine if inclusion of single shot regional technique improves patient/family satisfaction with post operative pain management .

Study Design:

Prospective randomized single blinded study.

Inclusion Criteria

  • Children aged between 6 yr and 17yr scheduled for ambulatory peripheral orthopedic surgery with moderate to severe postoperative pain.
  • Surgery of moderate duration (<2hr)
  • Surgery associated with minimal blood loss or fluid shifts (<10% total blood volume)
  • American Society of Anesthesiologists (ASA) classification 1 or 2
  • Parents able to understand follow up instructions and are able to reach at home by phone

Exclusion Criteria

  • Known allergy to local anesthetics
  • Preexisting neuropathy with sensory or motor deficits
  • Skin infection at site of needle placement
  • Parents refusal for peripheral nerve blocks

Detailed Description

80 children between the ages of 6yr and 17 yrs. scheduled for ambulatory peripheral orthopedic procedures in the operating rooms of Batson Children's Hospital will be enrolled in the study. Written informed consent will be obtained from the parents or legal guardian and assent will be obtained from patients when possible.

Once enrolled in the study, patients will be randomly assigned to one of two groups General anesthesia only (GA group) and General Anesthesia combined with regional anesthesia (RA group). Once the patients are brought to the operating room standard ASA monitors will be applied. After mask induction with O2/Nitrous oxide(N2O)/Sevoflurane(Sevo), a peripheral intravenous line will be inserted and secured. Additional IV medication propofol 2-3mg/kg will be given prior to insertion of appropriate size laryngeal mask airway (LMA). Patients in GA group will undergo the procedure under general anesthesia with Sevo/O2. Patients in the RA group will receive a peripheral nerve block appropriate for the procedure after induction of general anesthesia with O2/N2O/Sevo. The attending anesthesiologists will perform the nerve block under ultrasound guidance (Sonosite machine with high frequency probe) using 22G stimulating needle under aseptic precautions. 0.5% ropivacaine up to a total dose of 3mg/kg will be used for the block.

Anesthesia is maintained in both groups with O2/Sevo titrated to minimum alveolar concentration (MAC of) 1.5 . After surgical incision, doses of 0.05mg/kg morphine is given IV every 5 min as needed titrated to HR and BP within 10% change from baseline.

Additional IV morphine at the dose of 0.05mg/kg will be given every 10 minutes in the recovery room (PACU) as needed for pain ( Visual Analog score -VAS score >4). Total morphine consumption, length of recovery room stay and side effects such as nausea or vomiting will be recorded in the PACU.

The patients in the study will be given the following

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
6 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Children aged between 6 yr and 17yr scheduled for ambulatory peripheral orthopedic surgery with moderate to severe postoperative pain.
  • Surgery of moderate duration (<2hr)
  • Surgery associated with minimal blood loss or fluid shifts (<10% total blood volume)
  • ASA classification 1 or 2
  • Parents able to understand follow up instructions and are able to reach at home by phone

Exclusion Criteria

  • Known allergy to local anesthetics
  • Preexisting neuropathy with sensory or motor deficits
  • Skin infection at site of needle placement
  • Parents refusal for peripheral nerve blocks

Arms & Interventions

General

Active Comparator

General Anesthesia only

Intervention: General Anesthesia (Procedure)

General

Active Comparator

General Anesthesia only

Intervention: Opioids Morphine (Drug)

General

Active Comparator

General Anesthesia only

Intervention: Oral pain medication Acetaminophen with Hydrocodone (Drug)

Regional

Experimental

General Anesthesia combined with regional block

Intervention: Regional block (Procedure)

Regional

Experimental

General Anesthesia combined with regional block

Intervention: General Anesthesia (Procedure)

Regional

Experimental

General Anesthesia combined with regional block

Intervention: Local Anesthetic Ropivacaine (Drug)

Regional

Experimental

General Anesthesia combined with regional block

Intervention: Opioids Morphine (Drug)

Regional

Experimental

General Anesthesia combined with regional block

Intervention: Oral pain medication Acetaminophen with Hydrocodone (Drug)

Outcomes

Primary Outcomes

Total Hydrocodone Dose (mg/kg)

Time Frame: day 2 and day 8 after the surgery

Secondary Outcomes

  • Patient/Family Satisfaction With Pain Management(one week after the surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Madhankumar Sathyamoorthy

Assistant Professor

University of Mississippi Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Peripheral Nerve Blocks in Pediatric... | Clinical Trial